Chemoinformaics analysis of 1,25-dihydroxycholecalciferol
| Molecular Weight | 416.646 | nRot | 6 |
| Heavy Atom Molecular Weight | 372.294 | nRig | 19 |
| Exact Molecular Weight | 416.329 | nRing | 3 |
| Solubility: LogS | -4.455 | nHRing | 0 |
| Solubility: LogP | 3.878 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 76.8349 |
| nHD | 3 | BPOL | 44.1411 |
| QED | 0.52 |
| Synth | 4.516 |
| Natural Product Likeliness | 2.652 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.865 |
| Pgp-sub | 0.001 |
| HIA | 0.023 |
| CACO-2 | -4.749 |
| MDCK | 0.0000129 |
| BBB | 0.508 |
| PPB | 0.944972 |
| VDSS | 1.721 |
| FU | 0.0312738 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.477 |
| CYP2c19-inh | 0.134 |
| CYP2c19-sub | 0.717 |
| CYP2c9-inh | 0.291 |
| CYP2c9-sub | 0.399 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.228 |
| CYP3a4-inh | 0.084 |
| CYP3a4-sub | 0.574 |
| CL | 4.896 |
| T12 | 0.108 |
| hERG | 0.083 |
| Ames | 0.039 |
| ROA | 0.427 |
| SkinSen | 0.83 |
| Carcinogencity | 0.121 |
| EI | 0.011 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.634693 |